Xetra

Dermapharm Holding SE

At a glance

Most recent filing on May 15, 2026 — an open-market purchase by Themis Beteiligungs-Aktiengesellschaft on May 14, 2026.

We hold 4 visible filings, going back to October 30, 2025.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

All 4 shown

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Themis Beteiligungs-Aktiengesellschaft Closely associated person
€17,795,400Open-market buy
TradedMay 14, 2026FiledMay 15, 2026
Dreibholz, Christof Management board
€95,830Open-market buy
TradedJan 5, 2026FiledJan 7, 2026
Themis Beteiligungs-Aktiengesellschaft Closely associated person
€53,824,340Open-market buy
TradedDec 8, 2025FiledDec 10, 2025
Themis Beteiligungs-Aktiengesellschaft Closely associated person
€36,250,200Open-market buy
TradedOct 30, 2025FiledNov 3, 2025